Skip to main content
Top
Published in: BMC Medical Informatics and Decision Making 1/2008

Open Access 01-12-2008 | Research article

Adapting a Markov Monte Carlo simulation model for forecasting the number of Coronary Artery Revascularisation Procedures in an era of rapidly changing technology and policy

Authors: Haider R Mannan, Matthew Knuiman, Michael Hobbs

Published in: BMC Medical Informatics and Decision Making | Issue 1/2008

Login to get access

Abstract

Background

Treatments for coronary heart disease (CHD) have evolved rapidly over the last 15 years with considerable change in the number and effectiveness of both medical and surgical treatments. This period has seen the rapid development and uptake of statin drugs and coronary artery revascularization procedures (CARPs) that include Coronary Artery Bypass Graft procedures (CABGs) and Percutaneous Coronary Interventions (PCIs). It is difficult in an era of such rapid change to accurately forecast requirements for treatment services such as CARPs. In a previous paper we have described and outlined the use of a Markov Monte Carlo simulation model for analyzing and predicting the requirements for CARPs for the population of Western Australia (Mannan et al, 2007). In this paper, we expand on the use of this model for forecasting CARPs in Western Australia with a focus on the lack of adequate performance of the (standard) model for forecasting CARPs in a period during the mid 1990s when there were considerable changes to CARP technology and implementation policy and an exploration and demonstration of how the standard model may be adapted to achieve better performance.

Methods

Selected key CARP event model probabilities are modified based on information relating to changes in the effectiveness of CARPs from clinical trial evidence and an awareness of trends in policy and practice of CARPs. These modified model probabilities and the ones obtained by standard methods are used as inputs in our Markov simulation model.

Results

The projected numbers of CARPs in the population of Western Australia over 1995–99 only improve marginally when modifications to model probabilities are made to incorporate an increase in effectiveness of PCI procedures. However, the projected numbers improve substantially when, in addition, further modifications are incorporated that relate to the increased probability of a PCI procedure and the reduced probability of a CABG procedure stemming from changed CARP preference following the introduction of PCI operations involving stents.

Conclusion

There is often knowledge and sometimes quantitative evidence of the expected impacts of changes in surgical practice and procedure effectiveness and these may be used to improve forecasts of future requirements for CARPs in a population.
Appendix
Available only for authorised users
Literature
1.
go back to reference World Health Organization: World health report: reducing risks, promoting healthy life. 2002, Geneva: WHO World Health Organization: World health report: reducing risks, promoting healthy life. 2002, Geneva: WHO
2.
go back to reference Kovar MG, Collins JH, Dolozier J, Havlik R, Pokras R: Trends in the availability and Use of Medical Care for Coronary Heart Disease and Related Diseases. Trends in Coronary Heart Disease Mortality. The Influence of Medical Care. Edited by: Millicent W, Higgins RVL. 1988, Oxford, Oxford University Press Kovar MG, Collins JH, Dolozier J, Havlik R, Pokras R: Trends in the availability and Use of Medical Care for Coronary Heart Disease and Related Diseases. Trends in Coronary Heart Disease Mortality. The Influence of Medical Care. Edited by: Millicent W, Higgins RVL. 1988, Oxford, Oxford University Press
3.
go back to reference Gillam R, Gillum B, Francis C: Coronary revascularization and coronary angiography in the United States: trends in soradial differences. Journal of the American College of Cardiology. 1997, 29: 1557-62. 10.1016/S0735-1097(97)00089-2.CrossRef Gillam R, Gillum B, Francis C: Coronary revascularization and coronary angiography in the United States: trends in soradial differences. Journal of the American College of Cardiology. 1997, 29: 1557-62. 10.1016/S0735-1097(97)00089-2.CrossRef
4.
go back to reference Martin CA, Hobbs MS, Armstrong BK, De Klerk NH: Trends in the incidence of myocardial infarction in Western Australia between 1971 and 1982. American Journal of Epidemiology. 1989, 129: 655-68.PubMed Martin CA, Hobbs MS, Armstrong BK, De Klerk NH: Trends in the incidence of myocardial infarction in Western Australia between 1971 and 1982. American Journal of Epidemiology. 1989, 129: 655-68.PubMed
5.
go back to reference Hobbs MST, McCaul KA, Knuiman MW, Rankin JM, Gilfillan I: Trends in coronary artery revascularization procedures in Western Australia, 1980–2001. Heart. 2004, 90 (9): 1036-1041. 10.1136/hrt.2003.022160.CrossRefPubMedPubMedCentral Hobbs MST, McCaul KA, Knuiman MW, Rankin JM, Gilfillan I: Trends in coronary artery revascularization procedures in Western Australia, 1980–2001. Heart. 2004, 90 (9): 1036-1041. 10.1136/hrt.2003.022160.CrossRefPubMedPubMedCentral
6.
go back to reference Morice MC, Serruys PW, Sousa JE, Fajadet J, Ban Hayashi E, Perin M, Colombo A, Schuler G, Barragan P, Guagliumi G, Molnar F, Falotico R: Randomized Study with the Sirolimus-Coated Bx Velocity Balloon-Expandable Stent in the Treatment of Patients with de Novo Native Coronary Artery Lesions. New England Journal of Medicine. 2002, 346 (23): 1773-80. 10.1056/NEJMoa012843.CrossRefPubMed Morice MC, Serruys PW, Sousa JE, Fajadet J, Ban Hayashi E, Perin M, Colombo A, Schuler G, Barragan P, Guagliumi G, Molnar F, Falotico R: Randomized Study with the Sirolimus-Coated Bx Velocity Balloon-Expandable Stent in the Treatment of Patients with de Novo Native Coronary Artery Lesions. New England Journal of Medicine. 2002, 346 (23): 1773-80. 10.1056/NEJMoa012843.CrossRefPubMed
7.
go back to reference Grube E, Silber S, Hauptmann KE, Mueller R, Buellesfeld L, Gerckens U, Russell ME: TAXUS I: six- and twelve-month results from a randomized, double-blind trial on a slow-release paclitaxel-eluting stent for de novo coronary lesions. Circulation. 2003, 107 (1): 38-42. 10.1161/01.CIR.0000047700.58683.A1.CrossRefPubMed Grube E, Silber S, Hauptmann KE, Mueller R, Buellesfeld L, Gerckens U, Russell ME: TAXUS I: six- and twelve-month results from a randomized, double-blind trial on a slow-release paclitaxel-eluting stent for de novo coronary lesions. Circulation. 2003, 107 (1): 38-42. 10.1161/01.CIR.0000047700.58683.A1.CrossRefPubMed
8.
go back to reference Yusuf S, Zucker D, Peduzzi P, Fisher LD, Takaro T, Kennedy JW: Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration [see comments] [published erratum appears in Lancet 1994 Nov 19, 344(8934):1446]. Lancet. 1994, 344 (8922): 563-70. 10.1016/S0140-6736(94)91963-1.CrossRefPubMed Yusuf S, Zucker D, Peduzzi P, Fisher LD, Takaro T, Kennedy JW: Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration [see comments] [published erratum appears in Lancet 1994 Nov 19, 344(8934):1446]. Lancet. 1994, 344 (8922): 563-70. 10.1016/S0140-6736(94)91963-1.CrossRefPubMed
9.
go back to reference RITA-2: Coronary angioplasty versus medical therapy for angina: the second Randomised Intervention Treatment of Angina (RITA-2) trial. RITA-2 trial participants. Lancet. 1997, 350 (9076): 461-8. 10.1016/S0140-6736(97)07298-X. [see comments]CrossRef RITA-2: Coronary angioplasty versus medical therapy for angina: the second Randomised Intervention Treatment of Angina (RITA-2) trial. RITA-2 trial participants. Lancet. 1997, 350 (9076): 461-8. 10.1016/S0140-6736(97)07298-X. [see comments]CrossRef
10.
go back to reference Anderson GM, Grumbach K, Luft HS, Roos LL, Mustard C, Brook R: Use of coronary artery bypass surgery in the United States and Canada. Influence of age and income. JAMA. 1993, 269 (13): 1661-6. 10.1001/jama.269.13.1661.CrossRefPubMed Anderson GM, Grumbach K, Luft HS, Roos LL, Mustard C, Brook R: Use of coronary artery bypass surgery in the United States and Canada. Influence of age and income. JAMA. 1993, 269 (13): 1661-6. 10.1001/jama.269.13.1661.CrossRefPubMed
11.
go back to reference Higginson LA, Naylor CD: Rates of cardiac catheterization, coronary angioplasty and coronary artery bypass surgery in Canada. Canadian Journal of Cardiology. 1997, 13 (Suppl D): 47D-52D.PubMed Higginson LA, Naylor CD: Rates of cardiac catheterization, coronary angioplasty and coronary artery bypass surgery in Canada. Canadian Journal of Cardiology. 1997, 13 (Suppl D): 47D-52D.PubMed
12.
go back to reference Holman CD, Bass AJ, Rouse IL, Hobbs MS: Population-based linkage of health records in Western Australia: development of a health services research linked database, Australia and New Zealand. Journal of Public Health. 1999, 23: 453-9. Holman CD, Bass AJ, Rouse IL, Hobbs MS: Population-based linkage of health records in Western Australia: development of a health services research linked database, Australia and New Zealand. Journal of Public Health. 1999, 23: 453-9.
13.
go back to reference Mannan HR, Knuiman MW, Hobbs M: A Markov simulation model for analysing and forecasting the number of coronary artery revascularization procedures in Western Australia. Annals of Epidemiology. 2007, 17 (12): 964-975. 10.1016/j.annepidem.2007.05.016.CrossRefPubMed Mannan HR, Knuiman MW, Hobbs M: A Markov simulation model for analysing and forecasting the number of coronary artery revascularization procedures in Western Australia. Annals of Epidemiology. 2007, 17 (12): 964-975. 10.1016/j.annepidem.2007.05.016.CrossRefPubMed
14.
15.
go back to reference Treeage Pro: Treeage Pro User's Manual. 2005, Treeage software Inc., 1075 Main Street, Williamstown, MA 01267 Treeage Pro: Treeage Pro User's Manual. 2005, Treeage software Inc., 1075 Main Street, Williamstown, MA 01267
16.
go back to reference Brophy JM, Belisle P, Joseph L: Evidence of use of coronary stents: A hierarchical Bayesian meta-analysis. Annals of Internal Medicine. 2003, 138: 777-786.CrossRefPubMed Brophy JM, Belisle P, Joseph L: Evidence of use of coronary stents: A hierarchical Bayesian meta-analysis. Annals of Internal Medicine. 2003, 138: 777-786.CrossRefPubMed
17.
go back to reference Sesso HD, Chen RS, L'Italien GJ, Lapuerta P, Lee WC, Glynn RJ: Blood Pressure Lowering and Life Expectancy Based on a Markov Model of Cardiovascular Events. Hypertension. 2003, 42: 885-10.1161/01.HYP.0000097602.67134.4D.CrossRefPubMed Sesso HD, Chen RS, L'Italien GJ, Lapuerta P, Lee WC, Glynn RJ: Blood Pressure Lowering and Life Expectancy Based on a Markov Model of Cardiovascular Events. Hypertension. 2003, 42: 885-10.1161/01.HYP.0000097602.67134.4D.CrossRefPubMed
18.
go back to reference Antiplatelet Trialists' Collaboration: Collaborative overview of randomised trials of antiplatelet therapy–II: Maintenance of vascular graft or arterial patency by antiplatelet therapy. Antiplatelet Trialists' Collaboration [see comments]. British Medical Journal. 1994, 308 (6922): 159-68.CrossRef Antiplatelet Trialists' Collaboration: Collaborative overview of randomised trials of antiplatelet therapy–II: Maintenance of vascular graft or arterial patency by antiplatelet therapy. Antiplatelet Trialists' Collaboration [see comments]. British Medical Journal. 1994, 308 (6922): 159-68.CrossRef
19.
go back to reference Lipid Management Guidelines – 2001: National Heart Foundation of Australia and Cardiac Society of Australia and New Zealand. Medical Journal of Australia. 2001, 175: S57-85. Lipid Management Guidelines – 2001: National Heart Foundation of Australia and Cardiac Society of Australia and New Zealand. Medical Journal of Australia. 2001, 175: S57-85.
20.
go back to reference Shrive FM, Manns BJ, Galbraith Knudtson ML, Ghali WA: Economic evaluation of sirolimus-eluting stents. Canadian Medical Association Journal. 2005, 172 (3): 345-351. 10.1503/cmaj.1041062.CrossRefPubMedPubMedCentral Shrive FM, Manns BJ, Galbraith Knudtson ML, Ghali WA: Economic evaluation of sirolimus-eluting stents. Canadian Medical Association Journal. 2005, 172 (3): 345-351. 10.1503/cmaj.1041062.CrossRefPubMedPubMedCentral
21.
go back to reference Kong DF, Eisenstein EL, Sketch MH, Zidar JP, Ryan TJ, Harrington RA, Newman MF, Smith PK, Mark DB, Califf RM: Economic impact of drug-eluting stents on hospital systems: A disease-state model. American Heart Journal. 2204, 147 (3): 449-456. 10.1016/j.ahj.2003.11.005.CrossRef Kong DF, Eisenstein EL, Sketch MH, Zidar JP, Ryan TJ, Harrington RA, Newman MF, Smith PK, Mark DB, Califf RM: Economic impact of drug-eluting stents on hospital systems: A disease-state model. American Heart Journal. 2204, 147 (3): 449-456. 10.1016/j.ahj.2003.11.005.CrossRef
22.
go back to reference Whitfield M, Gillett M, Holmes M, Ogden E: Predicting the impact of population level risk reduction in cardio-vascular disease and stroke on acute hospital admission rates over a 5 year period – a pilot study. Public Health. 2006, 120 (12): 1140-1148. 10.1016/j.puhe.2006.10.012.CrossRefPubMed Whitfield M, Gillett M, Holmes M, Ogden E: Predicting the impact of population level risk reduction in cardio-vascular disease and stroke on acute hospital admission rates over a 5 year period – a pilot study. Public Health. 2006, 120 (12): 1140-1148. 10.1016/j.puhe.2006.10.012.CrossRefPubMed
Metadata
Title
Adapting a Markov Monte Carlo simulation model for forecasting the number of Coronary Artery Revascularisation Procedures in an era of rapidly changing technology and policy
Authors
Haider R Mannan
Matthew Knuiman
Michael Hobbs
Publication date
01-12-2008
Publisher
BioMed Central
Published in
BMC Medical Informatics and Decision Making / Issue 1/2008
Electronic ISSN: 1472-6947
DOI
https://doi.org/10.1186/1472-6947-8-27

Other articles of this Issue 1/2008

BMC Medical Informatics and Decision Making 1/2008 Go to the issue